Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 18 April 2012 of an increase in their interests in American Depositary Shares (ADSs) at a price of $44.74 per ADS following the re-investment of dividends paid to shareholders on 12 April 2012.
Mrs D P Connelly |
Acquisition of 14.826 ADSs under the personal contribution element of the Plan. |
|
|
Mr W C Louv
|
Notional increase of 15.143 ADSs under the matching element of the Plan (Company contribution).
Acquisition of 38.938 ADSs under the personal contribution element of the Plan.
Notional increase of 39.761 ADSs under the matching element of the Plan (Company contribution).
|
The afore-mentioned individuals have elected to participate in the Plan in respect of their 2010 bonus on a post-tax basis. The notional dividends accrued under the matching element will be paid out in proportion to the percentage of the participant's deferred annual bonus matching award holdings that will vest following the end of the relevant three year measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
19 April 2012